Clinical Trial: Expanded Access Protocol Using I131-MIBG

Study Status: Available
Recruit Status: Available
Study Type: Expanded Access

---

Official Title: An Open Label, Expanded Access Protocol Using 131I-metaiodobenzylguanidine (131I-MIBG)Therapy in Patients With Refractory Neuroblastoma, Pheochromocytoma, or Paraganglioma

Brief Summary:

Primary Objectives:

• Provide palliative therapy with 131I-MIBG for patients with advanced neuroblastoma, pheochromocytoma, or paraganglioma.
• Gain more information about acute and late toxicity of 131I-MIBG therapy for patients with refractory neuroblastoma, pheochromocytoma, or paraganglioma.